Target- |
MechanismCell replacements |
|
|
|
Inactive Indication- |
Drug Highest PhaseIND Application |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with Regend Therapeutics (ShangHai)Co. Ltd.
0 Patents (Medical) associated with Regend Therapeutics (ShangHai)Co. Ltd.
100 Deals associated with Regend Therapeutics (ShangHai)Co. Ltd.
100 Translational Medicine associated with Regend Therapeutics (ShangHai)Co. Ltd.